Hanan G. Abdulwahab
Cairo, C 11754, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
New Derivatives of 4-Piperidinylphenyl-Linked Thiazoles as VEGFR2 Inhibitors with Potential Cytotoxicity Against Renal Cancer.
Journal: Biomolecules
Published: January 29, 2026
Novel Benzosuberone/Indanone-Linked Thiazoles as Small-Molecule SARS-CoV-2 Main Protease Inhibitors.
Novel Benzosuberone/Indanone-Linked Thiazoles as Small-Molecule SARS-CoV-2 Main Protease Inhibitors.
Journal: Drug development research
Published: January 03, 2025
Discovery of novel benzimidazole derivatives as potent HDACs inhibitors against leukemia with (Thio)Hydantoin as zinc-binding moiety: Design, synthesis, enzyme inhibition, and cellular mechanistic study.
Journal: Bioorganic chemistry
Published: January 30, 2024
The patent review of the biological activity of tropane containing compounds.
Journal: Expert opinion on therapeutic patents
Published: January 02, 2024
Recent Methods for the Synthesis of Quinoxaline Derivatives and their Biological Activities.
Journal: Mini reviews in medicinal chemistry
Published: June 06, 2023
The most Recent Compilation of Reactions of Enaminone Derivatives with various Amine Derivatives to Generate Biologically Active Compounds.
Journal: Mini reviews in medicinal chemistry
Published: April 12, 2023
Discovery of new 1H-pyrazolo[3,4-d]pyrimidine derivatives as anticancer agents targeting EGFRWT and EGFRT790M.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: August 24, 2022
Novel benzimidazole-linked (thio)barbiturates as non-hydroxamate HDAC6 inhibitors targeting leukemia: Design, synthesis, and structure-activity relationship.
Journal: Archiv der Pharmazie
Published: August 15, 2022
An updated patent review of VEGFR-2 inhibitors (2017-present).
Journal: Expert opinion on therapeutic patents
Published: May 27, 2021
Novel thiobarbiturates as potent urease inhibitors with potential antibacterial activity: Design, synthesis, radiolabeling and biodistribution study.
Journal: Bioorganic & medicinal chemistry
Published: July 21, 2020
Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity.
Journal: Bioorganic chemistry
Published: July 16, 2020
Last Updated: 09/26/2026